Another component of this network that was ascertained as being upregulated in the ABC kind of DLBCL was IRF4 (Blenk et al., 2007), and the promoter for this gene is known to have NF-κB binding sites as well (Sharma et al., 2002). The gene discussed is IRF4; the disease is diffuse large B-cell lymphoma.